Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | AnaptysBio, Inc. ANAB |
BLACKROCK INC BLK |
1,900,844 6.200% |
-647,624 (-25.41%) |
Filing History |
| 2025-03-07 4:42 pm Purchase |
2025-02-28 | 13G | AnaptysBio, Inc. ANAB |
First Light Asset Management, LLC | 4,653,068 15.170% |
4,653,068 (New Position) |
Filing History |
| 2025-02-18 4:36 pm Purchase |
2025-02-14 | 13G | AnaptysBio, Inc. ANAB |
Point72 Asset Management, L.P. | 1,691,372 5.600% |
902,827 (+114.49%) |
Filing History |
| 2025-02-14 3:45 pm Sale |
2024-12-31 | 13G | AnaptysBio, Inc. ANAB |
Fairmount Funds Management LLC | 0 0.000% |
-1,671,484 (Position Closed) |
Filing History |
| 2025-02-14 11:27 am Sale |
2025-01-31 | 13G | AnaptysBio, Inc. ANAB |
Frazier Life Sciences Public Fund, L.P. | 463,241 1.500% |
-1,192,054 (-72.01%) |
Filing History |
| 2025-02-14 11:25 am Sale |
2024-12-31 | 13G | AnaptysBio, Inc. ANAB |
Frazier Life Sciences Public Fund, L.P. | 1,655,295 5.400% |
-261,896 (-13.66%) |
Filing History |
| 2025-02-05 1:23 pm Purchase |
2024-12-31 | 13G | AnaptysBio, Inc. ANAB |
BLACKROCK INC BLK |
2,548,468 8.400% |
748,645 (+41.60%) |
Filing History |
| 2024-12-18 4:30 pm Purchase |
2024-12-11 | 13G | AnaptysBio, Inc. ANAB |
Fairmount Funds Management LLC | 1,671,484 5.500% |
1,671,484 (New Position) |
Filing History |
| 2024-11-14 4:00 pm Purchase |
2024-09-30 | 13G | AnaptysBio, Inc. ANAB |
TANG CAPITAL MANAGEMENT LLC | 1,330,879 4.400% |
1,330,879 (New Position) |
Filing History |
| 2024-11-14 09:24 am Sale |
2024-09-30 | 13G | AnaptysBio, Inc. ANAB |
Deep Track Capital, LP | 0 0.000% |
-2,036,990 (Position Closed) |
Filing History |
| 2024-08-16 12:07 pm Purchase |
2024-08-14 | 13D | AnaptysBio, Inc. ANAB |
EcoR1 Capital LLC | 7,794,996 25.800% |
274,572 (+3.65%) |
Filing History |
| 2024-07-10 10:10 am Purchase |
2024-07-09 | 13G | AnaptysBio, Inc. ANAB |
FMR CORP | 2,870,618 10.507% |
2,692,879 (+1515.07%) |
Filing History |
| 2024-05-06 12:59 pm Purchase |
2024-04-29 | 13G | AnaptysBio, Inc. ANAB |
Frazier Life Sciences Public Fund, L.P. | 1,917,191 7.000% |
1,917,191 (New Position) |
Filing History |
| 2024-02-14 4:00 pm Sale |
2023-12-31 | 13G | AnaptysBio, Inc. ANAB |
TANG CAPITAL PARTNERS LP | 1,950,609 7.300% |
-678,069 (-25.80%) |
Filing History |
| 2024-02-14 10:01 am Sale |
2023-12-31 | 13G | AnaptysBio, Inc. ANAB |
Point72 Asset Management, L.P. | 788,545 3.000% |
-1,335,655 (-62.88%) |
Filing History |
| 2024-02-14 08:35 am Purchase |
2023-12-31 | 13G | AnaptysBio, Inc. ANAB |
Deep Track Capital, LP | 2,036,990 7.670% |
676,814 (+49.76%) |
Filing History |
| 2024-02-13 4:58 pm Sale |
2023-12-29 | 13G | AnaptysBio, Inc. ANAB |
The Vanguard Group | 1,380,115 5.190% |
-396,793 (-22.33%) |
Filing History |
| 2024-01-26 5:25 pm Sale |
2023-12-31 | 13G | AnaptysBio, Inc. ANAB |
BLACKROCK INC BLK |
1,799,823 6.800% |
-56,443 (-3.04%) |
Filing History |
| 2023-10-02 4:32 pm Purchase |
2023-09-22 | 13G | AnaptysBio, Inc. ANAB |
Deep Track Capital, LP | 1,360,176 5.120% |
1,360,176 (New Position) |
Filing History |
| 2023-02-14 4:21 pm Sale |
2022-12-31 | 13G | AnaptysBio, Inc. ANAB |
Point72 Asset Management, L.P. | 2,124,200 7.500% |
-157,000 (-6.88%) |
Filing History |